We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Westlake Chemical Corporation (WLK - Free Report) is a vertically integrated international producer and supplier of petrochemicals, polymers and fabricated products.
Earnings
Westlake Chemical’s adjusted earnings were $2.24 per share for first-quarter 2018. The figure beat the Zacks Consensus Estimate of $2.09 per share.
Revenues
Westlake Chemical posted first-quarter revenues of $2,150 million, up roughly 10.7% year over year. It beat the Zacks Consensus Estimate of $2,100.5 million.
Westlake Chemical Corporation Price and EPS Surprise
Investors should note that the earnings estimate for Westlake Chemical for the first quarter has been going up over the last month. Westlake Chemical has beaten the Zacks Consensus Estimate in three of the trailing four quarters while missing once, with an average beat of 18.4%.
Key Stats/Developments to Note
The company noted that demand for products in both the Olefins and Vinyls segments remained strong during the quarter due to continued growth in the Americas, Europe and Asia. Moreover, the company continues to benefit from the investments made last year to improve its operations and reliability.
Westlake Chemical is working diligently on the recently announced expansions in its Vinyls segment. It remains focused on capturing the targeted synergies and cost reductions along with other opportunities that will improve operations across the company.
Zacks Rank
Westlake Chemical currently has a Zacks Rank #1 (Strong Buy), but that could change following its earnings report which has just released. Meanwhile, you can see the complete list of today’s Zacks #1 Rank stocks here.
Market Reaction
Westlake Chemical’s shares were inactive following the release. It would be interesting to see how the market reacts to the results during the trading session today.
Check back later for our full write up on Westlake Chemical’s earnings report!
5 Medical Stocks to Buy Now
Zacks names 5 companies poised to ride a medical breakthrough that is targeting cures for leukemia, AIDS, muscular dystrophy, hemophilia, and other conditions.
New products in this field are already generating substantial revenue and even more wondrous treatments are in the pipeline. Early investors could realize exceptional profits.
Image: Bigstock
Westlake Chemical's (WLK) Q1 Earnings & Sales Beat Estimates
Westlake Chemical Corporation (WLK - Free Report) is a vertically integrated international producer and supplier of petrochemicals, polymers and fabricated products.
Earnings
Westlake Chemical’s adjusted earnings were $2.24 per share for first-quarter 2018. The figure beat the Zacks Consensus Estimate of $2.09 per share.
Revenues
Westlake Chemical posted first-quarter revenues of $2,150 million, up roughly 10.7% year over year. It beat the Zacks Consensus Estimate of $2,100.5 million.
Westlake Chemical Corporation Price and EPS Surprise
Westlake Chemical Corporation Price and EPS Surprise | Westlake Chemical Corporation Quote
Estimate Trend & Surprise History
Investors should note that the earnings estimate for Westlake Chemical for the first quarter has been going up over the last month. Westlake Chemical has beaten the Zacks Consensus Estimate in three of the trailing four quarters while missing once, with an average beat of 18.4%.
Key Stats/Developments to Note
The company noted that demand for products in both the Olefins and Vinyls segments remained strong during the quarter due to continued growth in the Americas, Europe and Asia. Moreover, the company continues to benefit from the investments made last year to improve its operations and reliability.
Westlake Chemical is working diligently on the recently announced expansions in its Vinyls segment. It remains focused on capturing the targeted synergies and cost reductions along with other opportunities that will improve operations across the company.
Zacks Rank
Westlake Chemical currently has a Zacks Rank #1 (Strong Buy), but that could change following its earnings report which has just released. Meanwhile, you can see the complete list of today’s Zacks #1 Rank stocks here.
Market Reaction
Westlake Chemical’s shares were inactive following the release. It would be interesting to see how the market reacts to the results during the trading session today.
Check back later for our full write up on Westlake Chemical’s earnings report!
5 Medical Stocks to Buy Now
Zacks names 5 companies poised to ride a medical breakthrough that is targeting cures for leukemia, AIDS, muscular dystrophy, hemophilia, and other conditions.
New products in this field are already generating substantial revenue and even more wondrous treatments are in the pipeline. Early investors could realize exceptional profits.
Click here to see the 5 stocks >>